longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Abbott Laboratories

ABT

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 32.90, within the reasonable range, cheaper than 30.7% of the time in the past 5 years, and the industry ranks 31/175, the industry Median -0.85.

32.9xP/E
$102.03Stock price
$3.10Earnings per share
32.9xP/E
Stock price$102.03Earnings per share$3.10

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
29.16x
Typical range
18.21x–34.37x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
011223344

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
ABTUSAbbott Laboratories
32.90x5.11%$177.70B
ISRGUSIntuitive Surgical
42.45x17.25%$133.24B
IDXXUSIDEXX Labs
35.31x12.89%$40.24B
DXCMUSDexCom
32.63x19.36%$32.62B
ITGRUSInteger
33.41x5.33%$4.29B
NVSTUSEnvista
41.81x313.05%$3.97B
OMCLUSOmnicell
38.08x2,358.33%$1.49B
VREXUSVarex Imaging
35.22x127.65%$778.47M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.